NCT06480383: Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
- State
- Under way
- Phase
- Phase 2
- People
- 705 planned
- Started
- 5 Aug 2024
- Primary completion
- 16 Mar 2027
- Arms
- ITI-1284 20 mg
- Results
- None posted
- 28 Jun 2024: Trial registered
- 5 Aug 2024: Trial started